Global measles mortality, 2000-2008
- PMID: 19959985
Global measles mortality, 2000-2008
Abstract
The United Nations (UN) Millennium Development Goals include a goal (MDG 4) to achieve a two thirds overall reduction of child deaths by 2015 compared with the 1990 level. Because many unvaccinated children die from measles, routine measles vaccination coverage is used as an indicator of progress toward this goal. In 2008, all UN member states reaffirmed their commitment to achieving a 90% reduction in measles mortality by 2010 compared with 2000, from an estimated 733,000 deaths in 2000 worldwide to <73,300 by 2010. The World Health Organization (WHO) and UNICEF have identified 47 priority countries with the highest burden of measles for an accelerated strategy for measles mortality reduction. The strategy includes 1) achieving and maintaining high coverage (>or=90% nationally and >or=80% in each district) with 2 doses of measles-containing vaccine (MCV) delivered through routine services or supplemental immunization activities (SIAs) , 2) implementing effective laboratory-supported disease surveillance, and 3) providing appropriate clinical management for measles cases. This report updates a previously published report, provides details on activities implemented during 2008, assesses progress toward the 2010 goal, and evaluates the potential effects of decreased financial support. During 2000--2008, global measles mortality declined by 78%, from an estimated 733,000 deaths in 2000 to 164,000 in 2008, but the reduction in measles mortality has been leveling off since 2007. To reach the 2010 goal, India should fully implement the recommended strategies, and financial support for sustaining measles control in the other 46 priority countries should be secured.
Similar articles
-
Progress in global measles control and mortality reduction, 2000-2007.MMWR Morb Mortal Wkly Rep. 2008 Dec 5;57(48):1303-6. MMWR Morb Mortal Wkly Rep. 2008. PMID: 19052529
-
Progress in global measles control and mortality reduction, 2000-2006.MMWR Morb Mortal Wkly Rep. 2007 Nov 30;56(47):1237-41. MMWR Morb Mortal Wkly Rep. 2007. PMID: 18046301
-
Progress in reducing global measles deaths, 1999-2004.MMWR Morb Mortal Wkly Rep. 2006 Mar 10;55(9):247-9. MMWR Morb Mortal Wkly Rep. 2006. PMID: 16528234
-
The unfinished measles immunization agenda.J Infect Dis. 2003 May 15;187 Suppl 1:S1-7. doi: 10.1086/368226. J Infect Dis. 2003. PMID: 12721885 Review.
-
Determining measles-containing vaccine demand and supply: an imperative to support measles mortality reduction efforts.J Infect Dis. 2003 May 15;187 Suppl 1:S22-8. doi: 10.1086/368274. J Infect Dis. 2003. PMID: 12721888 Review.
Cited by
-
Measles outbreak in Burkina Faso, 2009: a case-control study to determine risk factors and estimate vaccine effectiveness.Vaccine. 2012 Jul 13;30(33):5000-8. doi: 10.1016/j.vaccine.2012.05.024. Epub 2012 May 28. Vaccine. 2012. PMID: 22652399 Free PMC article.
-
Measles humoral and cell-mediated immunity in children aged 5-10 years after primary measles immunization administered at 6 or 9 months of age.J Infect Dis. 2013 Feb 15;207(4):574-82. doi: 10.1093/infdis/jis719. Epub 2013 Jan 8. J Infect Dis. 2013. PMID: 23300162 Free PMC article.
-
Measles in a measles-eliminated country: A case report of a measles-infected postpartum mother and infant in Japan.IDCases. 2021 May 9;24:e01157. doi: 10.1016/j.idcr.2021.e01157. eCollection 2021. IDCases. 2021. PMID: 34026544 Free PMC article.
-
Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaques.Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2987-92. doi: 10.1073/pnas.1017334108. Epub 2011 Jan 31. Proc Natl Acad Sci U S A. 2011. PMID: 21282608 Free PMC article.
-
Antivirals in medical biodefense.Virus Genes. 2020 Apr;56(2):150-167. doi: 10.1007/s11262-020-01737-5. Epub 2020 Feb 19. Virus Genes. 2020. PMID: 32076918 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical